These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1070 related articles for article (PubMed ID: 1964194)

  • 1. [The use of continuous cell cultures for the study of tumor heterogeneity and drug sensitivity].
    Del Bufalo D; Cucco C; Leonetti C
    Medicina (Firenze); 1990; 10(3):298-302. PubMed ID: 1964194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing.
    Cortazar P; Gazdar AF; Woods E; Russell E; Steinberg SM; Williams J; Ihde DC; Johnson BE
    Clin Cancer Res; 1997 May; 3(5):741-7. PubMed ID: 9815744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of apoptosis in four human tumour cell lines with differing sensitivities to cisplatin.
    Raaphorst GP; Mao J; Yang H; Goel R; Niknafs B; Shirazi FH; Yazdi HM; Rippstein P; Ng CE
    Anticancer Res; 1998; 18(4C):2945-51. PubMed ID: 9713489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance mechanisms in three human small cell lung cancer cell lines established from one patient during clinical follow-up.
    de Vries EG; Meijer C; Timmer-Bosscha H; Berendsen HH; de Leij L; Scheper RJ; Mulder NH
    Cancer Res; 1989 Aug; 49(15):4175-8. PubMed ID: 2545337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines.
    Nishio K; Ishida T; Arioka H; Kurokawa H; Fukuoka K; Nomoto T; Fukumoto H; Yokote H; Saijo N
    Anticancer Res; 1996; 16(6B):3387-95. PubMed ID: 9042196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer drug sensitivity profiles of new and established melanoma cell lines.
    Marshall ES; Holdaway KM; Shaw JH; Finlay GJ; Matthews JH; Baguley BC
    Oncol Res; 1993; 5(8):301-9. PubMed ID: 8012062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of DA-125, a novel anthracycline, in human gastric and pulmonary adenocarcinoma cells resistant to adriamycin and cisplatin.
    Hong WS; Jung HY; Yang SK; Kim HR; Min YI
    Anticancer Res; 1997; 17(5A):3613-6. PubMed ID: 9413212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
    Lai SL; Hwang J; Perng RP; Whang-Peng J
    Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up.
    Berendsen HH; de Leij L; de Vries EG; Mesander G; Mulder NH; de Jong B; Buys CH; Postmus PE; Poppema S; Sluiter HJ
    Cancer Res; 1988 Dec; 48(23):6891-9. PubMed ID: 2846164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of DNA topoisomerase II confers resistance to etoposide (VP-16) in small cell lung cancer cell lines established from a refractory tumor of a patient and by in vitro selection.
    Andoh T; Nishizawa M; Hida T; Ariyoshi Y; Takahashi T; Ueda R
    Oncol Res; 1996; 8(6):229-38. PubMed ID: 8895198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prospect for cisplatin analogs from the experimental standpoint].
    Tashiro T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1358-65. PubMed ID: 2543305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro cytotoxicity of a novel antitumor antibiotic, spicamycin derivative, in human lung cancer cell lines.
    Lee YS; Nishio K; Ogasawara H; Funayama Y; Ohira T; Saijo N
    Cancer Res; 1995 Mar; 55(5):1075-9. PubMed ID: 7866991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collateral sensitivity to thaliblastine and/or hyperthermia exhibited by a rat ovarian tumor cell line selected for resistance to cisplatin.
    Chen G; Zeller WJ; Todorov DK
    Anticancer Res; 1993; 13(5A):1269-75. PubMed ID: 8239496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
    Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
    Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
    Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic activity of azelaic acid against human melanoma primary cultures and established cell lines.
    Zaffaroni N; Villa R; Silvestro L; Sanfilippo O; Silvestrini R
    Anticancer Res; 1990; 10(6):1599-602. PubMed ID: 2285231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro chemosensitivity of human lung cancer cell lines.
    Ruckdeschel JC; Carney DN; Oie HK; Russell EK; Gazdar AF
    Cancer Treat Rep; 1987; 71(7-8):697-704. PubMed ID: 3038314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitous induction of resistance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells overexpressing isoforms 1 and 2 of dihydrodiol dehydrogenase.
    Deng HB; Adikari M; Parekh HK; Simpkins H
    Cancer Chemother Pharmacol; 2004 Oct; 54(4):301-7. PubMed ID: 15138708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line.
    Zijlstra JG; de Vries EG; Mulder NH
    Cancer Res; 1987 Apr; 47(7):1780-4. PubMed ID: 3028613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.